PADA-1 trial: ESR1 mutations in plasma ctDNA guide treatment switching

Nat Rev Clin Oncol. 2023 Feb;20(2):67-68. doi: 10.1038/s41571-022-00712-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers, Tumor / genetics
  • Breast Neoplasms*
  • Circulating Tumor DNA* / genetics
  • Estrogen Receptor alpha / genetics
  • Female
  • Humans
  • Mutation / genetics
  • Treatment Switching

Substances

  • Circulating Tumor DNA
  • Biomarkers, Tumor
  • Estrogen Receptor alpha